Assessing New Drugs in Advanced Cancer: Beyond Randomised Evidence

Saved in:
Bibliographic Details
Published in:Clinical oncology (Royal College of Radiologists (Great Britain)) 2021-04, Vol.33 (4), p.e201-e202
Main Authors: Dodwell, D., Shakir, R.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c400t-6848cb773f74b668ae25d3d6f61ae1bb602d4947cd266bd066796833d9725dec3
cites cdi_FETCH-LOGICAL-c400t-6848cb773f74b668ae25d3d6f61ae1bb602d4947cd266bd066796833d9725dec3
container_end_page e202
container_issue 4
container_start_page e201
container_title Clinical oncology (Royal College of Radiologists (Great Britain))
container_volume 33
creator Dodwell, D.
Shakir, R.
description
doi_str_mv 10.1016/j.clon.2020.11.003
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2463600406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0936655520304179</els_id><sourcerecordid>2463600406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-6848cb773f74b668ae25d3d6f61ae1bb602d4947cd266bd066796833d9725dec3</originalsourceid><addsrcrecordid>eNp9kE1PwzAMhiMEYuPjD3BAPXLpcJLWbRGXbYwPaQIJwTlqE3fKtLUj2Yb270m1wZGTJfvxK_th7IrDgAPH2_lAL9pmIECEBh8AyCPW54mUsShyfsz6UEiMMU3THjvzfg4AIs-LU9aTUggpc9lno6H35L1tZtErfUcPbjPzkW2iodmWjSYTjbvi7qIR7drGRO9lY9ql9WEy2VpDYXjBTupy4enyUM_Z5-PkY_wcT9-eXsbDaawTgHWMeZLrKstknSUVYl6SSI00WCMviVcVgjBJkWTaCMTKAGJWYC6lKbIAkpbn7Gafu3Lt14b8WoU7NC0WZUPtxiuRoESABDCgYo9q13rvqFYrZ5el2ykOqnOn5qpzpzp3inMV3IWl60P-plqS-Vv5lRWA-z1A4cutJae8tp0BYx3ptTKt_S__B5_wfhQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2463600406</pqid></control><display><type>article</type><title>Assessing New Drugs in Advanced Cancer: Beyond Randomised Evidence</title><source>Elsevier</source><creator>Dodwell, D. ; Shakir, R.</creator><creatorcontrib>Dodwell, D. ; Shakir, R.</creatorcontrib><identifier>ISSN: 0936-6555</identifier><identifier>EISSN: 1433-2981</identifier><identifier>DOI: 10.1016/j.clon.2020.11.003</identifier><identifier>PMID: 33223383</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-04, Vol.33 (4), p.e201-e202</ispartof><rights>2020 The Royal College of Radiologists</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-6848cb773f74b668ae25d3d6f61ae1bb602d4947cd266bd066796833d9725dec3</citedby><cites>FETCH-LOGICAL-c400t-6848cb773f74b668ae25d3d6f61ae1bb602d4947cd266bd066796833d9725dec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33223383$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dodwell, D.</creatorcontrib><creatorcontrib>Shakir, R.</creatorcontrib><title>Assessing New Drugs in Advanced Cancer: Beyond Randomised Evidence</title><title>Clinical oncology (Royal College of Radiologists (Great Britain))</title><addtitle>Clin Oncol (R Coll Radiol)</addtitle><issn>0936-6555</issn><issn>1433-2981</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PwzAMhiMEYuPjD3BAPXLpcJLWbRGXbYwPaQIJwTlqE3fKtLUj2Yb270m1wZGTJfvxK_th7IrDgAPH2_lAL9pmIECEBh8AyCPW54mUsShyfsz6UEiMMU3THjvzfg4AIs-LU9aTUggpc9lno6H35L1tZtErfUcPbjPzkW2iodmWjSYTjbvi7qIR7drGRO9lY9ql9WEy2VpDYXjBTupy4enyUM_Z5-PkY_wcT9-eXsbDaawTgHWMeZLrKstknSUVYl6SSI00WCMviVcVgjBJkWTaCMTKAGJWYC6lKbIAkpbn7Gafu3Lt14b8WoU7NC0WZUPtxiuRoESABDCgYo9q13rvqFYrZ5el2ykOqnOn5qpzpzp3inMV3IWl60P-plqS-Vv5lRWA-z1A4cutJae8tp0BYx3ptTKt_S__B5_wfhQ</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>Dodwell, D.</creator><creator>Shakir, R.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202104</creationdate><title>Assessing New Drugs in Advanced Cancer: Beyond Randomised Evidence</title><author>Dodwell, D. ; Shakir, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-6848cb773f74b668ae25d3d6f61ae1bb602d4947cd266bd066796833d9725dec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dodwell, D.</creatorcontrib><creatorcontrib>Shakir, R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical oncology (Royal College of Radiologists (Great Britain))</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dodwell, D.</au><au>Shakir, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessing New Drugs in Advanced Cancer: Beyond Randomised Evidence</atitle><jtitle>Clinical oncology (Royal College of Radiologists (Great Britain))</jtitle><addtitle>Clin Oncol (R Coll Radiol)</addtitle><date>2021-04</date><risdate>2021</risdate><volume>33</volume><issue>4</issue><spage>e201</spage><epage>e202</epage><pages>e201-e202</pages><issn>0936-6555</issn><eissn>1433-2981</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33223383</pmid><doi>10.1016/j.clon.2020.11.003</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0936-6555
ispartof Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-04, Vol.33 (4), p.e201-e202
issn 0936-6555
1433-2981
language eng
recordid cdi_proquest_miscellaneous_2463600406
source Elsevier
title Assessing New Drugs in Advanced Cancer: Beyond Randomised Evidence
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T17%3A07%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessing%20New%20Drugs%20in%20Advanced%20Cancer:%20Beyond%20Randomised%20Evidence&rft.jtitle=Clinical%20oncology%20(Royal%20College%20of%20Radiologists%20(Great%20Britain))&rft.au=Dodwell,%20D.&rft.date=2021-04&rft.volume=33&rft.issue=4&rft.spage=e201&rft.epage=e202&rft.pages=e201-e202&rft.issn=0936-6555&rft.eissn=1433-2981&rft_id=info:doi/10.1016/j.clon.2020.11.003&rft_dat=%3Cproquest_cross%3E2463600406%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c400t-6848cb773f74b668ae25d3d6f61ae1bb602d4947cd266bd066796833d9725dec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2463600406&rft_id=info:pmid/33223383&rfr_iscdi=true